Friday, 12 November 2010

MRCP revision battle 47.3: Acute Interstitial Nephritis

Interstitial nephritis is inflammation of the renal interstitium.



Acute interstitial nephritis

This is an immune reaction to drugs or infection.
It accounts for 2% of all acute renal failure but 25% of drug-induced renal failure.


Features include:
  • acute renal failure
  • hypertension
  • systemic symptoms
    • rash
    • fever
    • eosinophilia, raised IgE

>1% urinary eosinophils suggests diagnosis


Renal biopsy would show infiltration of the renal interstitium with:
  • T lymphocytes
  • macrophages
  • plasma cells

Causes include:
  • infections: hanta virus, leptospirosis, mycobacterium, staph, strep
  • drugs: methicillin, NSAIDs, rifampacin, allopurinol, penicillin, cephalosporins, furosemide, thiazides, amphotericin, aspirin
  • sarcoid

Lets move on to consider a hat-trick of causes of chronic interstitial nephritis

MRCP revision battle 47.4: Chronic interstitial nephritis

Chronic interstitial nephritis/tubulointerstitial nephritis can be caused by many conditions and results in fibrosis and tubular loss which manifests clinically as chronic renal failure




Analgesic nephropathy

Analgesic nephropathy is associated with long-term use of NSAIDs, and to a lesser degree paracetamol.


It may present as:
  • sterile pyuria
  • chronic renal failure
  • renal pain (due to papillary necrosis)

An IVU will show 'cup and spill' calyces
Renal biopsy may show interstitial nephritis

Treatment is to stop the analgesics and managed any renal failure.


There is an increased risk of urothelial tumours.




Reflux Nephropathy

Reflux nephropathy is defined as small and irregularly scarred kidneys associated with vesico-ureteric reflux.

Almost always only occurs in first 5 yrs of life.

Associated with an increased risk of renal stones.



Balkan Nephropathy

Balkan nephropathy is a chronic interstitial renal disease found in a distribution along the River Danube.

It is associated with coppery yellow pigmentation of palms and soles.
There is raised beta 2 microglobinuria.

Urothelial malignancy is much increased - up to 200x risk.




Now on to Alport's syndrome...

MRCP revision battle 47.5: Alport's syndrome

Alport's syndrome is an inherited kidney disease with an incidence of 1 in 5000.

It is inherited in an X-linked dominant fashion 85% of the time; 15% are autosomal recessive.


Alport's is an abnormality in the gene that codes for type IV collagen.


It is associated with:
  • abnormal GBM - 'basket weave' --> chronic renal failure, 30% nephrotic
  • sensorineural deafness
  • occular defects in 40%
    • lenticonus = bulging lens capsule on slit lamp exam
    • retinitis pigmentosa

Treatment is treating symptoms.

Onwards...

MRCP revision battle 47.6: Renal papillary necrosis

Renal papillary necrosis is a form of nephropathy involving the renal papilla (= location where medullary pyramids empty urine into minor calyx)


It can cause pain and a sterile pyuria.


An IVU may show 'cup and spill' calyces.


Causes of renal papillary necrosis may be recalled as 'POSTCARDS'
  • pyelonephritis
  • obstruction of renal tract
  • shock
  • TB
  • cirrhosis of liver
  • analgesic nephropathy
  • renal transplant rejection
  • diabetes
  • sickle cell


On to the final battle of the day, mesangiocapillary glomerulonephritis...

MRCP revision battle 47.7: Mesangiocapillary glomerulonephritis

Mesangiocapillary glomerulonephritis, also known as membranoproliferative glomerulonephritis is a rare form of glomerulonephritis.


There are 3 subtypes:


Type 1:
  • subendothelial immune deposits
  • caused by cryoglobulinaemia, hepatitis C
  • also associated with:
    • hep B
    • bacterial endocarditis
    • SLE
    • malaria
    • sickle cell disease
Type 2:
  • intramembranous electron-dense material --> 'double tramline'
  • associated with partial lipodystrophy
  • C3b nephritic factor present in 70%
  • low C3

Type 3:
  • associated with hepatitis B and C

Treatment is with steroids

50% of patients progress to end stage renal failure.

Thursday, 11 November 2010

MRCP revision battle 46.1: Classification of bacteria

A completely random mixed bag today, bursting full of random nuggets of MRCP knowledge...


MRCP revision battle 46.1: Classification of bacteria
MRCP revision battle 46.2: Tumour supressor genes and Li Fraumeni Syndrome
MRCP revision battle 46.3: Mitochondrial disorders and Leber's Optic Atrophy
MRCP revision battle 46.4: Cytotoxic Agents
MRCP revision battle 46.5: Congenital infections
MRCP revision battle 46.6: Rheumatoid factor
MRCP revision battle 46.7: Lichen Planus





MRCP revision battle 45.1: Classification of bacteria


MRCP questions just love commenting on the colour/shape of bacteria.  Hopefully my simple picture below (which was also stuck next to the loo during finals!) might help you.  Note that gram positive bacteria have walls so stain purple/blue while gram negative bacteria don't and stain pink.




My way of remembering them is 'SES ('says') ABCD then L....MN then all the rest'


As well as their colour/shape their 'pattern' is useful to know too:
  • pairs of cocci (= diplococci): neisseria gonorrhoea, neisseria meningitidis
  • chains of cocci: streptococci, enterococci
  • clumps of cocci: staphylococci


Now for some genetics...

MRCP revision battle 46.2: Tumour supressor genes and Li Fraumeni Syndrome

Tumour supressor genes code for proteins that provide a 'stop' signal to prevent cell division.  They therefore act as a barrier to the development of cancer.  As they are recessive genes both copies of the gene would have to be mutated to stop functioning.


The most famous tumour supressor gene is p53.

p53 is:
  • found on chromosome 17
  • the most commonly mutated gene in breast, colon and lung cancer
  • a key regulator of apoptosis and prevents entry into the S phase of the cell cycle until the DNA is checked.


Li Fraumeni Syndrome is a rare condition in which there is an autosomal dominant p53 mutation.  More rarely it may be caused by a CHEK-2 mutation. Li Fraumeni syndrome is characterised by early onset of cancer, especially breast, sarcoma or soft tissue.  



Lets move on to mitochondrial disorders...

MRCP revision battle 46.3: Mitochondrial disorders and Leber's Optic Atrophy

mDNA mutates 10x more frequently than normal DNA.  However, there is a poor genotype to phenotype correlation so the mutations are often not noticed.


Since sperm do not contain mitochondria mitochondrial disorders are passed exclusively from mother to child.


The most famous mitochondrial disorders are:

  1. Kearns Sayre - see battle 15.5
  2. Leber's hereditary optic neuropathy.
  3. Some forms of sensorineural deafness


Leber's hereditary optic neuropathy
  • mDNA mutation
  • progressive loss of central vision due to optic atrophy, begins in young adulthood
  • if LHON 'plus' also:
    • multiple-sclerosis type symptoms
    • Wolff-Parkinson White


Next up - some cytotoxic agents (which sadly sounds more exciting than it is)

MRCP revision battle 46.4: Cytotoxic Agents

A quick run-through of the main mechanisms of action and MRCP-relevant side-effects of some common cytotoxic agents.


Vincristine
  • Inhibits microtubule formation
  • Used in:
    • lyphoma
    • leukaemia
    • breast and lung cancer
  • Side effects
    • peripheral paraesthesia
    • loss of tendon reflexes
    • abdominal pain

Cisplatin
  • Cross-links DNA
  • Used in:
    • testicular, cervical, bladder, lung, head and neck cancers
  • Side effects
    • nephrotoxic
    • ototoxic
    • peripheral neuropathy
    • hypomagnesaemia
    • myelosupression


Bleomycin
  • Degrades DNA
  • Used in:
    • metastatic germ cell cancers
    • non-Hodgkins lymphoma
  • Side effects
    • increased pigmentation
    • pulmonary fibrosis


Doxorubicin
  • inhibits RNA/DNA synthesis
  • used in:
    • leukaemia
    • lyphoma
    • breast cancer
  • Side effects
    • red colouration of urine
    • SVT
    • cardiomyopathy

Methotrexate
  • inhibits dihydrofolate reductase
  • used in:
    • non-Hodkins lymphoma
    • choriocarcinoma
    • RA
  • Side effects
    • excreted by kidneys so should be avoided in renal disease
    • should be avoided in significant ascites/pleural effusion as may accumulate then suddenly return to circulation causing myelosupression
    • myelosupression
    • mucositis
    • pneumonitis


Cyclophosphamide
  • alkylating --> cross links DNA. Inactive until metabolised by liver
  • used in:
    • CLL
    • lymphoma
    • sarcoma
  • Side effects
    • haemorrhagic cystitis 


To continue the randomness of the 46th set of battles lets look at congential infections

MRCP revision battle 46.5: Congenital infections

A few short notes on 5 infections mummies may have during pregnancy which can adversely affect the fetus...


Maternal rubella
  • fetus is nearly always affected if rubella occurs during first 7 weeks of gestation
  • fetus is nearly always OK if rubella occurs after 17 weeks of gestation
  • Effects of rubella on fetus:
    • sensorineural deafness
    • congenital cateracts
    • congenital heart disease
    • glaucoma


Maternal toxoplasmosis
  • fetus will only be affected if it is the first time the mother is exposed, unless she is immunosupressed
  • classical triad is:
    • cerebral calcification
    • hydrocelphalus
    • chorioretinitis


Maternal chickenpox
  • if this occurs during the 1st trimester risk of limb deformity
  • if mum has been in contact with chickenpox and is not sure if she is immune test for antibodies and if no natural immunity give immunoglobulin


Maternal CMV
  • at least 75% of fetus' exposed to CMV are undamaged
  • however, there is a risk of:
    • intracranial calcification
    • microcephaly
    • cardiac/GI abnormalities

Maternal Parvovirus B19
  • generally either fetal death or complete recovery


Now for a spot of rheumatoid factor

MRCP revision battle 46.6: Rheumatoid factor

Rheumatoid factor is an autoantibody against the Fc portion of IgG.  

Rheumatoid factor is found in 4% of the 'normal' population and 25% of elderly.


Rheumatoid factor is positive in low titres in chronic infections, for example:
  • 10% syphyllis
  • 20% pulmonary TB
  • 50% leprosy


Rheumatoid factor is often positive in high titres in connective tissue disease, for example it is positive in:
  • 70% of patients with RA
  • virtually 100% of patients with RA with extra-articular manifestations
  • >75% sjogrens
  • 20-40% SLE
  • 30% scleroderma

It may also be present in other immunological diseases, for example autoimmune liver disease or sarcoidosis.


Very high titres of rheumatoid factor may be found in cryoglobulinaemias


Rheumatoid factor is only useful in RA as an assessment of prognosis.  It is not useful for diagosis or or measuring level of activity.


Rheumatoid factor is detected by the Rose-Waaler test (sheep red cell agglutination) or the latex agglutination test.


Now to the final battle of the day - lichen planus

MRCP revision battle 46.7: Lichen Planus

Lichen planus is an intensely itchy rash characterised by purple papules with flat tops, often with white lines on the surface (=Wickham's striae).

The picture below (taken by Dr Tag-El -Din Anbar) illustrates lichen planus on an arm:




Mucus membranes may also be affected.


Management may be symptomatic, or with steroid creams.

Half of cases have resolved within 6 to 9 months and the majority of the rest will be gone within 18 months.



A lichenoid-like rash can also be caused by some medications, including:
  • NSAIDS
  • thiazide diuretics
  • antimalarials
  • betablockers
  • gold injections
  • mercury fillings

Wednesday, 10 November 2010

MRCP revision battle 45.1: Dialysis and complications

Back to my old nemesis renal medicine for another 7 battles...


MRCP revision battle 45.1: Dialysis and complications
MRCP revision battle 45.2: Anaemia in chronic renal failure
MRCP revision battle 45.3: Diuretics
MRCP revision battle 45.4: Proteinuria
MRCP revision battle 45.5: Renal osteodystrophy
MRCP revision battle 45.6: Radio-contrast nephropathy
MRCP revision battle 45.7: Minimal change disease




MRCP revision battle 45.1: Dialysis and complications


Lets start with a very matter-of-fact battle on dialysis and its complications


Brief overview of types of renal replacement therapy
  1. Haemodialysis
    • semi-permeable membrane
    • solute transfer by diffusion
    • excess fluid removed by creating a negative transmembrane pressure = ultrafiltration
  2. Haemofiltration
    • highly permeable membrane
    • solute transfer by convection
    • ultrafiltrate replaced by an equal volume of substitute fluid
    • takes longer and is more expensive than haemodialysis but less haemodynamic instability so used for critically ill patients
  3. Peritoneal dialysis
    • dialysis fluid put into abdominal cavity via tenchkoff catheter
    • solutes diffuse across peritoneal membrane
    • ultrafiltration achieved by adding glucose to the dialysis fluid

Complications of dialysis
  • Disequilibration syndrome
    • occurs on initial dialysis
    • manifests as nausea, vomiting, headache and altered consciousness
    • caused by rapid changes in plasma osmolality
  • Vascular disease
  • Heart valve calcification - especially aortic valve
  • Beta-2 microglobulin amyloidosis
  • Arthritis
  • Infections


Now to consider anaemia in renal failure...

MRCP revision battle 45.2: Anaemia in chronic renal failure

Anaemia is common in chronic renal failure and is usually due to:
  • decreased production of erythropoetin
  • iron deficiency

Treatment should be considered when Hb <11
The target for treatment should be Hb between 10.5 and 12.5


Correct any iron deficiency first; note that oral iron is often not enough and IV iron therapy may be needed.


If there is still anaemia the likely eryropoetin deficiency must be addressed.  Options are:
  • Eryropoetin replacement with either epoetin (=recombinant human erythropoetin) or 
  • darbepoetin (=hyperglycosylated derivative of epoetin with a longer half life)

Side effects of epoetin include:
  • hypertension (25%)
  • bone aches
  • 'flu'
  • rashes, urticaria
  • pure red cell aplasia 
    • low reticulocyte count
    • anaemia
    • antibodies
  • increased risk of DVT as increased PCV

If no response to epoetin consider if the patient has an infection, inflammatory condition or aluminium toxicity, all of which can impair epoetin's effectiveness.


Note that blood transfusions are generally avoided in renal patients as they would make matching for transplants more difficult



Cross your legs as we move on to a battle of diuretics...

MRCP revision battle 45.3: Diuretics

Before I started my revision I thought I was very au-fait with diuretics - after all, I prescribe them daily.  However, a quick bond with the British National Formulary revealed some interesting gems.  So here's a quick recap of diuretics with a sprinkling of hopefully new information.



1. Loop diuretics
  • work on the Na-K-2Cl transporter in the ascending loop of Henle
  • examples include furosemide and bumetanide
  • bumetanide is 40x more potent than furosemide for the same dose
  • both work within 30 mins (if given IV) or 1 hr (if given orally) and their action is completed within 6 hours
  • possible side effects include:
    • hypokalaemia/natraemia
    • retention if enlarged prostate
    • tinnitus 
    • pancreatitis

2. Thiazide diuretics
  • work on the Na-Cl co-transporter in the DCT
  • examples include bendroflumethiazide, indapamide and metolazone
  • they work within 1 to 2 hours and have a duration of action of 12 to 24 hours
  • possible side effects include:
    • hypokalaemia/naturaemia
    • hyperglycaemia
    • pancreatitis

3. Aldosterone antagonists
  • work by antagonising aldosterone 
  • examples include spironolactone and eplerenone 
  • possible side effects include:
    • hyperkalaemia
    • impotenence
    • gynaecomastia


Now for the differentials of proteinuria...

MRCP revision battle 45.4: Proteinuria

Normal protein excretion in urine is <150mg/day


Causes of proteinura include:
  • Renal causes
    • UTI
    • glomerulonephritis
    • myeloma
    • diabetes
    • hypertension
    • amyloid
  • Extra-renal causes
    • fever
    • exercise
    • psoriasis
    • pregnancy

Orthostatic proteinuria is proteinuria which disappears when recumbant.   The cause of this is unknown but it is felt to be benign.


On to renal osteodystrophy...

MRCP revision battle 45.5: Renal osteodystrophy

Renal osteodystrophy refers to the bone pathology which results from the endocrine and electrolyte imbalances caused by chronic renal failure.


Derangements include:
  • raised phosphate
  • low calcium
  • secondary hyperparathyroidism
  • low vitamin D
  • acidosis

The result on bones include:
  • osteomalacia
  • osteitis fibrosa cystica = hyperparathyroid bone disease
  • osteoporosis
  • osteosclerosis 'rugger jersey' spine

Management is:
  • calcichew - to bind phosphate in the gut
  • vit D analogues - eg adcal D3/calceos/calcichew = colecalciferol


On to the slightly more stimulating contrast nephropathy...

MRCP revision battle 45.6: Radio-contrast nephropathy

Radiocontrast nephropathy complicates up to 10% of procedures involving contrast.

Contrast nephropathy presents as non-oliguric acute renal failure 1 to 5 days post procedure.


Risk of contrast nephropathy can be reduced by:
  • good hydration/normal saline
  • oral n.acetyl cysteine

Risk of contrast nephropathy is increased by:
  • increased amount of contrast
  • hypovolaemia
  • myeloma
  • increasing age
  • diabetes
  • raised calcium
  • chronic renal failure

Remember that metformin must be withheld before and for 48 hrs post IV contrast due to risk of lactic acidosis. 




Now to end on a high with a battle with minimal change disease...

MRCP revision battle 45.7: Minimal change glomerulonephritis

Minimal change glomerulonephritis almost always presents as nephrotic syndrome

It is responsible for 80% of cases of nephrotic syndrome in children and around a quarter of cases in adults.


Its name 'minimal change' comes from the fact that under a light microscope the kidney looks normal; if an electron microscope is used you can see podocyte fusion.


Minimal change glomerulonephritis causes a highly selective proteinuria with only smaller proteins leaked.


Most causes are idiopathic but 10-20% are associated with:
  • NSAIDs/gold/rifampacin
  • hodgkins, thyroma
  • mononucleosis

It is believed to be T-lymphocyte mediated.


Treatment is with corticosteroids - 80% of cases respond
Cyclophosphamide can be used in non-responders.


The prognosis for minimal change glomerulonephritis is (fairly) good:
  • 1/3 recover completely
  • 1/3 suffer infrequent relapses
  • 1/3 suffer frequent relapses
  • BUT - <1% proceed to end-stage renal failure


Tomorrow's battles will be a completely random bag, then a final renal push (the end of the hattrick) will occur the day after.

Tuesday, 9 November 2010

MRCP revision battle 44.1: Antipsychotic medication

Today is a psychiatry and overdose fest...


MRCP revision battle 44.1: Antipsychotic medication
MRCP revision battle 44.2: SSRIs
MRCP revision battle 44.3: Serotonin syndrome
MRCP revision battle 44.4: Baby blues, post natal depression and psychosis
MRCP revision battle 44.5: Quinine toxicity/overdose
MRCP revision battle 44.6: Theophylline overdose
MRCP revision battle 44.7: Ethylene glycol poisoning



MRCP revision battle 44.1: Antipsychotic medication

Antipsychotic medications are used in the treatment of schizophrenia, severe anxiety, mania and occasionally for their sedative properties.

Antipsychotic medications have an immediate sedative action but their antipsychotic action may tak up to 3 weeks to become effective.


Atypical antipsychotics

Atypical antipsychotics are the newer drugs.  They produce a highly selective blockade of the mesolimbic D2 receptors and serotonin 5HT2A receptors.

Examples include amisulperide, olanzapine, quetiapine, risperidone and clozapine.


Side effects include:
  • weight gain
  • nausea, dyspesoa
  • hyperglucaemia and impaired glucose tolerance
  • increased risk DVT
  • increased risk stroke (especially olanzapine and risperidone)
  • clozapine only:
    • 1% agranulocytosis/neutropenia - therefore weekly blood tests for 1st 6 months then fortnightly afterwards
    • 3% seizures

All antipsychotics have roughly the same effectiveness except clozapine, which is better.  However, in light of its worse side effect profile clozapine is only recommended if 2 others have already failed.


Typical antipsychotics

Typical antipsychotics are the older drugs,
Examples include haloperidol, chorpromazine, phenothiazine and sulperide.


Side effects of the typical antipsychotics include:
  • extrapyramidal side effects
  • anticholingergic effects
  • antihistaminergic effects
  • photosensitivity (especially phenothiazine)
  • prolonged QT
  • lower seizure threshold
  • hyperprolactinaemia.


Now on to SSRIs...